Hi Marilyn and Andrea,
Thanks for clarifying that point for me, it makes more sense now! I have to
say though I am concerned by our government's willingness to throw these
interventions around. Similar to the birth dose of Hep B, I really don't
think there is true informed consent. I have had some clients go and have
their partner's blood group and Hep B status checked, rather than administer
something that may have some risk attached which may not necessarily be
beneficial in their situation.
Cheers,
Nicole.

----- Original Message ----- 
From: "Marilyn Kleidon" <[EMAIL PROTECTED]>
To: <[EMAIL PROTECTED]>
Sent: Wednesday, October 27, 2004 10:49 AM
Subject: Re: [ozmidwifery] Re:


> Nicole:
>
> I think perhaps you are confusing giving anti-D prophylactically (usually
> given once at 28weeks if antibody negative and then again postnatally if
the
> baby is Rh pos) with treating a possible sensitising event.
>
> When given prophylactically the "life" of the antibodies is thought to be
> around 12 weeks, theoretically should a sensitising event occur in this
time
> period then these antibodies will take care of it. If the event were
> significant then perhaps another dose would be given with appropriate
blood
> work (antibodies etc.. and FCAD).
>
> When treating a possibly sensitising event: when foetal blood cells would
> mix with maternal ones eliciting and immuune response and hence a "memory"
> in the mother's immune system which would make her sensitised then the
time
> period is 3 days or 72hrs. This time period is not the life of the
> antibodies but the time interval within which the potentially sensitised
> person will NOT from antibodies, hence if the anti-D is given within this
> time period the anti-D will destroy the foetal blood cells before the
> mother's immune system can respond and form a memory. Potentially
> sensitising events include: spontaneous or intended abortion, placental
> abruption, small unnoticed placental bleeds, threatened miscarriage with
or
> without observed bleeding, amniocentisis, ecv, birth, retained placenta,
and
> similar events.
>
> Once a mother has been sensitised then that is it in the sense that future
> pregnancies will  need to be monitored and antibody titres done to ensure
> the well being of the baby in the interests of preventing HDN if possible.
>
> There are many issues around anti-D not the least being that it is a blood
> product and thus a potential source of blood born contaminants/pathogens.
I
> do believe to date the actual processing needed to produce these
antibodies
> from sensitised donors has prevented the transmition of the blood born
> pathogens. Nevertheless the potential remains and we would be fools to
> ignore it, the scientific community certainly doesn't ignore it.
>
> Other issues have included the potential for these antibodies to cross the
> placenta and start destroying the baby's blood cells themselves. If this
has
> happened I have not known it to be a significant issue: that is not the
> source of significant hemolysis or anaemia in neonates possibly because
the
> supply is limited and not able to replicate itself. Another issue is the
> possibility for the antibodies to sensitise an Rh negative baby, again I
> don't think this has ever been recorded and to be honest doesn't make
> immunological sense to me but that doesn't mean it couldn't happen (I am
not
> an immunologist).
>
> Anti-D has been given prophylactically in various communities around the
> world since the late 1960's and has been extremely effective in preventing
> HDN. As with all medications informed consent should be given. Have you
> visited Sara Wickham's site at http://www.withwoman.co.uk/.
>
> marilyn
> ----- Original Message ----- 
> From: "Nicole Carver" <[EMAIL PROTECTED]>
> To: <[EMAIL PROTECTED]>
> Sent: Monday, October 25, 2004 2:40 AM
> Subject: [ozmidwifery] Re:
>
>
> > Hi Kristin,
> > I have concerns about the reasoning behind the giving of anti D in
> > pregnancy. It is apparently done because some women develop anti D
> > antibodies without any obvious clinical events that can be treated with
> anti
> > D when they occur. (Previously anti D was only given if there was an
event
> > whereby foetal cells could enter the maternal circulation). I can't
> > understand how giving anti D twice in pregnancy can prevent antibody
> > formation for the whole pregnancy, when after birth, it must be given
> within
> > 72 hours to be effective. If the same period of action applies in
> pregnancy,
> > wouldn't it have to be given every three days throughout the pregnancy?
> > Perhaps someone can set me straight on this? The other thing I am
> concerned
> > about is the wide scale use of a blood product on pregnant women. I feel
> > certain that many women are not giving true informed consent to this.
> > Kind regards,
> > Nicole Carver.
> >
> > ----- Original Message ----- 
> > From: "Kristin Beckedahl" <[EMAIL PROTECTED]>
> > To: <[EMAIL PROTECTED]>
> > Sent: Monday, October 25, 2004 6:52 PM
> >
> >
> > >
> > >
> > > Dear List,
> > >
> > > I have recently heard of the Anti-D that can be given during pregnancy
> > > (28weeks?) for the prevention of HDN... does anyone know how effective
> it
> > > is, and if it is safe...? Thanks, Kristin
> > >
> > >
> > > --
> > > This mailing list is sponsored by ACE Graphics.
> > > Visit <http://www.acegraphics.com.au> to subscribe or unsubscribe.
> >
> >
> > --
> > This mailing list is sponsored by ACE Graphics.
> > Visit <http://www.acegraphics.com.au> to subscribe or unsubscribe.
>
>
> --
> This mailing list is sponsored by ACE Graphics.
> Visit <http://www.acegraphics.com.au> to subscribe or unsubscribe.
>


--
This mailing list is sponsored by ACE Graphics.
Visit <http://www.acegraphics.com.au> to subscribe or unsubscribe.

Reply via email to